子宮頸癌
子宮頸癌在全球最常見的女性癌癥個案中位居第二,二零零五年的子宮頸癌新癥超過500萬宗,有接近26萬名女性死於此癌癥。在香港,子宮頸癌是女性最常見的癌癥之壹,全無約有450宗新個案、每年死亡人數約為150人。
 
子宮頸癌疫苗是什麽
子宮頸癌疫苗又名HPV疫苗,是壹種預防性疫苗。它能預防因HPV16型和HPV18型感染而引致占總數七成的子宮頸癌。
 
子宮頸癌疫苗的成效如何
子宮頸癌疫苗對從未感染HPV16型和HPV18型病毒的女性最為有效。據目前資料顯示,此疫苗能100%預防由HPV16型和HPV18型病毒感染引致的癌前病變(子宮頸上皮內瘤)。由於疫苗並不能預防其他高風險類型的人類乳頭瘤病毒的感染,而且它亦不能清除已受感染女士的病毒,所以疫苗並不可以取締子宮頸細胞檢驗。
 

 
如何接種子宮頸癌疫苗
婦女須在六個月內接受三次疫苗註射,才能得到全面的保護。目前研究顯示,此疫苗的效力最少可以維持五年,但是否需要註射加強劑仍有待進壹步的研究數據。
 
在接種疫苗前需要接受檢查嗎
1、不需要。醫生只會詢問您的身體狀況是否適合接種疫苗,而不需要做任何檢查。
2、但已接種疫苗的女性仍需定期進行柏氏抹片檢查。
 
子宮頸癌疫苗安全嗎
1、世界衛生組織(WHO)已經認同加衛苗的安全性。
2、此疫苗不具有病毒基因或任何具傳染性的物質,所有並不會引致感染或HPV相關的病毒。
 
子宮頸癌疫苗有沒有副作用
壹般而言,子宮頸癌疫苗是安全的。常見的副作用與其他疫苗相似,包括註射位置紅腫和疼痛、發燒和頭痛。直至有更多關於疫苗對懷孕影響的資料前,懷孕婦女應避免接種此疫苗。此外,亦不建 議對此疫苗的任何成分曾產生過敏反應的人士接種此疫苗。
 
需要接受子宮頸癌疫苗人群
子宮頸癌疫苗的功效,對從未感染人類乳頭瘤病毒的女性最為顯著,因此,它最適合從未有性行為的女性。至於曾有性生活的女士,疫苗的功效因人而異,疫苗並不建議使用於孕婦。若接受疫苗後始發現懷孕,請向醫生查詢何時在繼續療程。

子宮頸癌疫苗的種類

市面上主要有兩款子宮頸癌疫苗,分別為4合1加衛苗(Gardasil)及九合一(Gradasil 9)。
這兩款子宮頸癌疫苗均可針對最少七成由HPV病毒引致的子宮頸癌。
9合1(Cervarix) ①注射后可對抗9種高風險致癌的病毒.
②9歲以上任何年齡都可註射 沒有上限.
③子宮頸癌疫苗9合1(Gradasil 9)的註射程序包括三次疫苗註射,註射程序分別為0,2及6個月.
.
加衛苗4合1(Gardasil)                                           ①有基本的七成子宮頸癌保護.
②可用於9-45歲的女性,預防陰道癌及性病濕疣(椰菜花).

③可用於9-26多的男性,預防性病濕疣(椰菜花).
④子宮頸癌疫苗加衛苗4合1(Gardasil)的註射程序包括三次疫苗註射,註射程序分別為0,2及6個月.

子宮頸癌疫苗的效果能維持多久
● 美國疾病控制及預防中心((CDC)於2011加衛苗壹疫苗信息(VIS)指出,預期HPV疫苗能提供長久保護,不需要打加強劑。
● 免疫記憶及疫苗提供長期保護的壹個重要指標,據研究顯示,加衛苗能產生強大的免疫記憶反應。
● 自2002年起,加衛苗已於丹麥,挪威,冰島及瑞典四國進行長期研究,以評估加衛苗的長期效用及安 全數據。研究至今數據顯示,實註射疫苗後,仍十分有效。
● 加衛苗已於全球醫生處方量超過7,400萬劑,超過124個國家註冊使用。包括香港衛生署及美國食品及藥物管理局(FDA)。
● 而美國、法國、丹麥、德國及加拿大等十多國政府均壹致認同加衛苗能預防更多HPV相關疾病及更符合經濟效益,所以選擇將加衛苗列為唯壹全民免疫註射計劃的指定子宮頸癌疫苗。
● 加衛苗獨有專利AAHS佐劑,比傳統配方能引起更強的兔疫反應,並已廣泛地用於數百萬人士身上,效用及安全性都已被肯定。

子宮頸癌疫苗的註射流程
婦科檢查  ---> 醫生診斷是否合適註射 ---> 疫苗註射

香港宝仁诊所HPV宫颈癌疫苗

Cervical cancer
Cervical cancer is the second most common cancer in the world, with more than 2005 new cases of cervical cancer and 5 million cases of cervical cancer, and nearly 260 thousand women die from the disease. In Hongkong, cervical cancer is the most common cancer in women, there are about 450 new cases, the number of deaths each year about 150 people.
 
What is the cervical cancer vaccine
Cervical cancer vaccine, also known as HPV vaccine, is a preventive vaccine. It can prevent cervical cancer, which accounts for 70% of the total number of infections caused by type HPV16 and type HPV18 infections.

How is the effect of cervical cancer vaccine
Cervical cancer vaccine is the most effective for women who have never been infected with type HPV16 and type HPV18 virus. According to the current information, the vaccine can be 100% to prevent the disease caused by type HPV16 and type HPV18 virus infection of precancerous lesions (cervical intraepithelial neoplasia). Because the vaccine does not prevent other high-risk types of human papilloma virus infection, but it can not remove the virus has been infected with the woman, so the vaccine can not be banned cervical cell test.

How to be inoculated with cervical cancer vaccine
Women must receive three vaccine injections within six months to get a comprehensive protection. Current research shows that the effectiveness of this vaccine can be maintained for at least five years, but whether the need for injection of reinforcing agent is still to be further research data.

Need to be examined before vaccination
1,do not need. The doctor will only ask if your body is fit to be vaccinated, and not to be checked.
2,women have been vaccinated, but still need to conduct regular Pap tests of PAT'S.
 
Cervical cancer vaccine safety
1,the WHO (WHO) has accepted safety added Wei seedlings.
2,the vaccine does not have a viral gene or any infectious substances, all and will not cause infection or HPV related virus.

Cervical cancer vaccine has no side effects?
In one case, the cervical cancer vaccine is safe. Common side effects are similar to other vaccines, including injection site swelling and pain, fever, and headache. Until there is more information on the impact of the vaccine on pregnancy, pregnant women should avoid vaccination. In addition, it is not recommended that any of the ingredients of this vaccine have been vaccinated against the allergic reaction.
Need to accept the cervical cancer vaccine population
The efficacy of cervical cancer vaccine is most significant for women who have never been infected with human papillomavirus, so it is best for women who have never had sexual behavior. As for women who have had sexual life, the vaccine's efficacy varies from person to person, and the vaccine is not recommended for pregnant women. If you receive a pregnancy after receiving the vaccine, please consult your doctor for when to continue the course of treatment.

香港宝仁医疗诊所宫颈癌疫苗九合一加卫苗

Types of cervical cancer vaccine
There are two main models of cervical cancer vaccine on the market were 4 1 and nine added Wei Miao (Gardasil) one (Gradasil 9).
These two cervical cancer vaccines can be for at least 70% of cervical cancer caused by the HPV virus.
9 in 1 (Cervarix)
①after the injection of 9 kinds of high risk of the virus can fight cancer.
②9 years of age or older can be injected, there is no limit.
③Cervical cancer vaccine 9 in 1 (Gradasil 9) of the injection procedures,including the three vaccine injection, injection procedures were 0, 2 and 6 months.


 
4 and 1 added Wei Miao (Gardasil)                                                                                             ①70% cervical cancer protection.
②for women aged 9-45, prevention of vaginal carcinoma and condyloma acuminatum (cauliflower).
③available for 9-26 number of men, the prevention of sexually transmitted diseases acuminatum (cauliflower).
④Cervical cancer vaccine 4 and 1 added Wei Miao (Gardasil) injection procedures including three vaccine injection procedures were 0, 2 and 6 months.

The effect of cervical cancer vaccine can maintain how long
● The U.S. Centers for Disease Control and Prevention (CDC) to 2011 (a vaccine information added Wei Miao (VIS) pointed out that the expected HPV vaccine can provide long-term protection, did not need to strengthen agent.
● Immune memory and vaccines provide long-term protection of one important index, according to the study, added Wei Miao can produce strong immune memory responses.
● Since 2002, has added Wei Miao in Denmark, Norway, Iceland and Sweden did long-term studies, to long-term effectiveness and safety assessment of the data added Wei miao. Study data show that the data show that after the injection of the vaccine is still very effective.
● The doctor has added Wei Miao in the global prescription volume of more than 74 million agents, more than 124 countries registered for use. Including the Hongkong Department of health and the United States Food and Drug Administration (FDA).
● While the United States, France, Denmark, Germany and Canada's more than and 10 governments are a consensus added Wei Miao can prevent more HPV related diseases and more cost-effective, so the choice will be listed as the only one added Wei Miao national immunization programme of the cervical cancer vaccine designated uterus.
● Added Wei Miao patented AAHS adjuvant, than the traditional formula can cause immune reaction, and has been widely used in millions of people, utility and safety has been confirmed.
 
Injection Technological process of cervical cancer vaccine
Gynecological examination--->Doctor's diagnosis is suitable for injection--->Vaccine injection

宫颈癌疫苗(HPV)

宫颈癌疫苗(HPV)

子宮頸癌在全球最常見的女性癌癥個案中位居第二,二零零五年的子宮頸癌新癥超過500萬宗,有接近26萬名女性死於此癌癥。在香港,子宮頸癌是女性最常見的癌癥之壹,全無約有450宗新


预约挂号

扫描二维码分享到微信